MedPath

Omega-3 effects on Patient with attention deficit hyperactivity disorder

Not Applicable
Conditions
Attention deficit hyperactivity disorder.
Disturbance of activity and attention
Registration Number
IRCT201304035393N3
Lead Sponsor
Islamic Azad University of Yazd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
85
Inclusion Criteria

( Children with Score > 65 on both parents and teachers version of Conners rating scale; IQ > 70 using Kaufman brief intelligence test; Informed consent) (

Exclusion Criteria

occurrence of unintended side effects;previous treatment of ADHD; omega 3 supplement consumption during past 3 months;severe psychiatric disorders )

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Connors standard test for ADHD patients. Timepoint: 4 weeks. Method of measurement: Questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath